CitedRx rates 9 testosterone replacement therapy (TRT) telehealth providers out of 10. Testosterone is a Schedule III controlled substance, FDA-approved only for diagnosed hypogonadism: lab-confirmed low testosterone, not just "feeling low energy." Whether a provider requires bloodwork before prescribing is the clearest quality signal in this category, and it's weighted accordingly.
Concierge-style TRT with comprehensive bloodwork (hormone panel, metabolic, CBC, lipids) at intake and roughly every 6 months thereafter.
Comprehensive lab-first onboarding means the TRAVERSE and T Trials evidence in our research library applies directly to who gets prescribed.
At-home 40+ biomarker finger-stick panel required before prescribing, with labs repeated every 3-6 months.
Highest review volume of any provider in this set, with lab-confirmed prescribing throughout.
Baseline lab panel (free/total T, LH, FSH, PSA, CBC) required before prescribing, with follow-up labs bundled into a flat monthly fee.
Lowest-cost option among the top-rated, lab-first providers.
All nine require lab-confirmed diagnosis before prescribing: the differentiators are rating, pricing clarity, and lab-panel rigor.
| # | Provider | CitedRx Score | Labs required? | Best for | From |
|---|---|---|---|---|---|
| 1 | Defy Medical | 9.4/10 | Yes | Comprehensive, optimization-focused labs | ~$2,400/yr |
| 2 | Hone Health | 9.4/10 | Yes | At-home labs, strong ratings | $135/mo |
| 3 | Peter MD | 9.4/10 | Yes | Affordable flat pricing, labs included | $79/mo |
| 4 | Marek Health | 8.9/10 | Yes | Extensive lab panels via LabCorp | ~$225/mo |
| 5 | Maximus Tribe | 8.3/10 | Yes | Oral, cream, and injectable options | $99.99/mo |
| 6 | Fountain | 8.1/10 | Yes | Flat $199/mo all-inclusive | $199/mo |
| 7 | Low T Center | 8.0/10 | Yes (in-person draw) | Accepts insurance, hybrid model | $25 first test |
| 8 | TRT Nation | 7.3/10 | Yes | Flat $99/mo, unlimited consults | $99/mo |
| 9 | Viking Alternative Medicine | 7.0/10 | Yes | Compounded protocols via partner pharmacy | ~$99-299/mo |
TRT Nation's Trustpilot rating (2.0/5, 28 reviews) is notably lower than peers. Maximus Tribe's parent company received an FDA warning letter (June 2026) over compounded GLP-1 marketing claims: a different product line, unrelated to its TRT service; disclosed here for transparency but not scored against its TRT offering. See our research library for full evidence and citations.
Scores are CitedRx's own composite, not a clinical endorsement. Score order reflects the factors above, not payment from a provider. CitedRx may earn a referral fee if you sign up through a link on this page: see the disclosure in the footer.
The 2023 TRAVERSE trial (n=5,246, NEJM) found testosterone therapy was not associated with an increased rate of major adverse cardiovascular events versus placebo (7.0% vs 7.3%, noninferior). It did find higher rates of atrial fibrillation (3.5% vs 2.4%) and venous thromboembolism (1.7% vs 1.2%) as secondary findings, so cardiovascular monitoring still matters, but the core heart-attack/stroke/CV-death fear was not borne out.
Hypogonadism is a diagnosed clinical condition confirmed by lab-tested low testosterone (typically under 300 ng/dL on two morning blood draws) plus symptoms: this is the FDA-approved indication and what clinical trials like TRAVERSE studied. "Low T" is a marketing term, not a clinical diagnosis. A legitimate provider requires bloodwork before prescribing; one that doesn't is prescribing outside what the evidence actually supports.
Because it's the clearest quality signal in this category: a provider that requires lab-confirmed low testosterone before prescribing is treating a diagnosed condition the trial evidence actually applies to, while a provider prescribing off a symptom questionnaire alone is not. Every provider CitedRx ranked in this category does require labs, but the rigor varies.
Not according to the NIH-funded T Trials (2016): testosterone improved sexual function, mood, and bone density in older men with confirmed low T, but showed no meaningful improvement in energy/vitality or cognitive function.
Yes. Testosterone is a Schedule III controlled substance. Legitimate telehealth providers require lab-confirmed diagnosis and appropriate prescribing safeguards, not just an online questionnaire.
Typically $99-$300/month including medication, though some providers bill labs and consults separately, which can push annual costs to $2,500-$5,400 depending on the provider and how comprehensive the lab panel is.
CitedRx is an independent information resource and is not affiliated with the telehealth providers listed above. Pricing, ratings, and regulatory status are sourced from provider sites and public reviews; figures can change and should be confirmed with the provider directly. This page is for informational purposes only and is not medical advice: talk to a licensed clinician before starting or changing any medication. Testosterone is a Schedule III controlled substance. CitedRx may earn a referral fee if you sign up with a provider through a link on this page; this does not affect score or ranking order.